ROUTINE BIOCHEMICAL DIAGNOSIS AND PROGNOSIS OF COVID-19 SEVERITY IN THE CONDITIONS OF THE REGIONAL HOSPITAL

Authors:

Abstract:

The purpose of the study was to evaluate routine laboratory indicators of biochemical blood analysis as markers of potential risk and factors of infection with COVID-19 and the severity of respiratory failure in both women and men. This single-center retrospective study was conducted with the participation of 57 COVID-19-positive individuals hospitalized at the Rivne Regional War Veterans Hospital in October-November 2021. Blood urea levels were higher in respiratory failure group 1 than in respiratory failure group 2 in both women and men. The dynamics of creatinine levels in women and men with COVID-19 in all groups were the same. as well as blood urea levels. The level of total protein in women with COVID-19 decreased with the progression of respiratory failure to stage II, while in men, on the contrary, it increased. Female COVID-19 patients with grade I respiratory failure have higher total protein than male grade I respiratory failure, and female patients with grade 2 respiratory failure have lower total protein levels in women than in men. The dynamics of the level of albumin in women and men with COVID-19 in all groups was the same as the level of total protein. Based on ROC analysis, Kaplan-Meier method; univariate analysis using the log-rank test and the Cox regression model found that blood urea and creatinine levels are biomarkers of the development of respiratory failure (I or II) within 30 days after hospitalization in patients with COVID-19, both women and men.

Keywords:

COVID-19 biochemical indicators ROC analysis

References:

1. Alirezaei T, Hooshmand S, Irilouzadian R. The role of blood urea nitrogen to serum albumin ratio in the prediction of severity and 30-day mortality in patients with COVID-19. Health Sci Rep. 2022;5: e606. doi: 10.1002/hsr2.606.
2. Alwani M, Yassin A, Al-Zoubi RM, Aboumarzouk OM, Nettleship J, Kelly D, et al. Sex-based differences in severity and mortality in COVID-19. Rev Med Virol. 2021 Nov;31(6): e2223. doi: 10.1002/rmv.2223.
3. Gao YD, Ding M, Dong X. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021; 76:428–455. doi: 10.1111/all.14657.
4. Hu H, Pan H, Li R. Increased circulating cytokines have a role in COVID-19 severity and death with a more pronounced effect in males: a systematic review and meta-analysis. Front Pharmacol. 2022; 13:802228.
5. Huang D, Yang H, Yu H. Blood urea nitrogen to serum albumin ratio (BAR) predicts critical illness in patients with coronavirus disease 2019 (COVID-19). Int J Gen Med. 2021; 14:4711–21. doi: 10.2147/IJGM.S326204.
6. Hussein HJ, Ibrahim SA, Al-Shaibani SW, Abdulrudha NH. Association of Covid-19 with blood type A in relation to blood sugar, urea, and blood test (D-dimer and ferritin) in patients from Al-Najaf. J Med Life. 2022;15(2):180-187. doi:10.25122/jml-2021-0239.
7. Izcovich A, Ragusa MA, Tortosa F. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020;15(11 November). doi: 10.1371/journal.pone.0241955.
8. Komarevtseva IO, Ihnatova AYu, Rudenko IV, Kalinin IV, Zhurba OA, Balabanova KV, et al. Sphingosine-1-phosphate as a biomarker and predict of the development of severe acute respiratory syndrome in patients with COVID-19 and community-acquired pneumonia. World of Medicine and Biology. 2023; 86(4): 79–85. doi: 10.26724/2079-8334-2023-4-86-79-85.
9. Li LQ, Huang T, Wang YQ. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020; 92:577–583. doi: 10.1002/jmv.25757.
10. Malik P, Patel U, Mehta D. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2021; 26:107–8. doi: 10.1136/bmjebm-2020-111536.
11. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. Published online 2020:389–399. doi:10.1080/10408363.2020.1770685.
12. Zhang J Jin, Dong X, Liu G Hui, Gao Y Dong. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clin Rev Allergy Immunol. 2023; 64(1):90–107. doi:10.1007/s12016-022-08921-5.

Publication:

«World of Medicine and Biology» Vol. 20 No. 89 (2024) , с. 88-93
УДК 616.61-006:616.65+576.367

DOI:

https://doi.org/10.26724/2079-8334-2024-3-89-88-93